Updates

MP Evans

November 2022

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

Indonesian palm oil producer MP Evans posted a 49% increase in operating profit to US$61.7m. Eps increased 65% to 63.3 cents. This was driven largely by pricing with mill-gate CPO +43%, albeit partially offset by a 27% rise in cost per tonne. Volumes were unchanged but a strong performance in July and August means they have increased 5% year to date. Pricing has since pulled back in recent months due to lower demand following the Ukraine related price spike alongside numerous changes to the Indonesian tax and export regime, albeit now stabilized.Production from the company’s owned hectares increased 4% to 556,800 tonnes in 2021. The overall total (including independent smallholders) was unchanged at 705,700. Peel Hunt says th ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Playetch - Debt repayment to save €20m by end next year

Michelmersh

MP Evans - Investors valuing its palm oil plantations at 40% discount in spite of growth (June 2024)

MP Evans (August 2022)

MP Evans - Massive eps upgrades as palm oil prices soar (May 2022)

MP Evans - Palm oil business to double production by 2025 (March 2018)

MP Evans - Rejects 740p a share offer (January 2017)

MP Evans (July 2013)

MP Evans (January 2013)

MP Evens (December 2012)

MP Evans - Trading at 34% discount to NAV (June 2012)

MP Evans - H1 profit up 86% (November 2011)

MP Evans - On track for big production increase (July 2011)

MP Evans - Rise in palm oil prices and planted up area to drive eps upgrades (December 2010)

MP Evans - Higher prices offset lower production (June 2008)

MP Evans - Expanding palm oil producer (December 2007)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

MP Evans

November 2022

Related Articles